Beste Rhabdomyosarkom pädiatrische Onkologen in der Türkei - TOP -17 Ärzte

• Dr. Yesim Yildirim ist auf die Behandlung von Rhabdomyosarkomen spezialisiert.
• Experte für Chemotherapie, Strahlentherapie und Chirurgie bei Rhabdomyosarkomen.
• Nutzt gezielte Therapie und Immuntherapie als fortschrittliche Behandlungsoptionen.
• International ausgebildet, unter anderem in Israel und im Vereinigten Königreich.
• Zertifiziert von der Europäischen Gesellschaft für Medizinische Onkologie (ESMO).
• Mitglied mehrerer onkologischer Gesellschaften, darunter ESMO.
• Berät Patienten online und spricht Englisch, Russisch (Niveau B1) und Türkisch.

Experience

2021 - 2022

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2021 - 2022

Department of Radiation Oncology, Biruni University Faculty of Medicine

2020 - 2021

Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital

2017 - 2020

Clinical Manager of Radiation Oncology, Neolife Medical Center

2016 - 2017

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2011 - 2016

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2010 - 2011

Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine

2008 - 2010

Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)

2006

Medical Faculty, Dokuz Eylül University

2006 - 2008

Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)

2000 - 2006

Medical Faculty, Dokuz Eylül University

Education

2022

Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor

2022

Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism

2021

Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member

2017

Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor

2006

Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service

2006

Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization

1998

Ege University, Faculty of Medicine

• Spezialisiert auf die Behandlung von Rhabdomyosarkomen mittels Operation, Chemotherapie und Bestrahlung.
• Internationale Praxis in der Türkei und den USA (Krankenhaus für Spezialchirurgie).
• Renommierter Sarkomspezialist mit Schwerpunkt auf Knochen- und Weichteiltumoren.
• Mitglied der Türkischen Gesellschaft für Orthopädie und Traumatologie.
• Teil der European Musculo-Skeletal Oncology Society für Sarkomversorgung.
• Bietet Online-Konsultationen für Patienten mit Rhabdomyosarkom an.
• Er spricht fließend Türkisch und Englisch und bedient einen breiten Patientenstamm.

• Spezialisiert auf Rhabdomyosarkom, einen seltenen Muskelkrebs bei Kindern.
• Verwendet Chemotherapie, Strahlentherapie und Operation bei Rhabdomyosarkom.
• Internationale Praxis in der Türkei und den USA.
• Professor an der Universität Istanbul, der zukünftige Onkologen prägt.
• Verfasser von mehr als 70 Artikeln, die das Wissen über die Behandlung von Rhabdomyosarkomen erweitern.
• Bietet Online-Konsultationen und verbessert so den Patientenzugang.
• Spricht Türkisch und Englisch und erleichtert so die Kommunikation.

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation